AX vs CRL · P/E 11, rev $81.3M vs rev $2.00B
Axos Financial Inc (AX) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Axos Financial Inc (AX) is a banks - regional company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported AX revenue for 2026-06-30 was $81.3M. Net income was $490.4M. Revenue was up 23.5% from 2025-06-30 to 2026-06-30. AX currently screens at market cap $4.94B and trailing P/E 10.6.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
AX currently screens at market cap $4.94B and trailing P/E 10.6. CRL currently screens at market cap $7.78B.
Not investment advice. Open the AX and CRL stock pages for the full models.
Not investment advice.